Cited by 20

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Mutations in the SORT1 gene are unlikely to cause autosomal dominant hypercholesterolemia

Tveten, Kristian, Strøm, Thea Bismo, Cameron, Jamie, Berge, Knut Erik, Leren, Trond P.·2012·Atherosclerosis

Abstract

Objective To study whether mutations in the SORT1 gene could be a cause of autosomal dominant hypercholesterolemia and to study the effect of sortilin on the binding and internalization of low density lipoprotein (LDL). Methods 842 unrelated hypercholesterolemic subjects without mutations in genes known to cause autosomal dominant hypercholesterolemia, were screened for mutations in the SORT1 gene by DNA sequencing. Transfections of wild-type or mutant SORT1 plasmids in HeLa T-REx cells and the use of siRNA were used to study the effect of sortilin on the number of cell-surface LDL receptors and on the binding and internalization of LDL. Results A total of 45 mutations in the SORT1 gene were identified of which 15 were missense mutations. Eight of these were selected for in vitro studies, of which none had a major impact on the amount of LDL bound to the cell surface. There was a positive correlation between the amount of sortilin on the cell surface and the amount of LDL bound. The observation that a mutant sortilin which is predominantly found on the cell surface rather than in post-Golgi compartments, bound very high amounts of LDL, indicates that sortilin does not increase the binding of LDL through an intracellular mechanism. Rather, our data indicate that sortilin binds LDL on the cell surface. Conclusion Even though sortilin binds and internalizes LDL by receptor-mediated endocytosis, mutations in the SORT1 gene are unlikely to cause autosomal dominant hypercholesterol…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.atherosclerosis.2012.10.026

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 9

  1. Petersen, 1997, Molecular identification of a novel candidate sorting receptor purified from human brain by receptor-associated protein affinity chromatography, J Biol Chem, 272, 3599, 10.1074/jbc.272.6.3599 · DOI · Paper page
  2. Quistgaard, 2009, Ligands bind to sortilin in the tunnel of a ten-bladed β-propeller domain, Nat Struct Mol Biol, 16, 96, 10.1038/nsmb.1543 · DOI
  3. Willnow, 2008, VPS10P-domain receptors – regulators of neuronal viability and function, Nat Rev Neurosci, 9, 899, 10.1038/nrn2516 · DOI
  4. Willnow, 2011, Sortilins: new players in lipoprotein metabolism, Curr Opin Lipidol, 22, 79, 10.1097/MOL.0b013e3283416f2b · DOI
  5. Kjolby, 2010, Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export, Cell Metab, 12, 213, 10.1016/j.cmet.2010.08.006 · DOI · Paper page
  6. Dubé, 2011, Sortilin: an unusual suspect in cholesterol metabolism, Bioessays, 33, 430, 10.1002/bies.201100003 · DOI
  7. Linsel-Nitschke, 2010, Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary heart disease, Atherosclerosis, 208, 183, 10.1016/j.atherosclerosis.2009.06.034 · DOI · Paper page
  8. Cameron, 2006, Effect of mutations in the PCSK9 gene on the cell surface LDL receptors, Hum Mol Genet, 15, 1551, 10.1093/hmg/ddl077 · DOI · Paper page
  9. Sherry, 2001, dbSNP: the NCBI database of genetic variation, Nucleic Acids Res, 29, 308, 10.1093/nar/29.1.308 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Tveten, K., Strøm, T. B., Cameron, J., Berge, K. E., & Leren, T. P.
Venue
Atherosclerosis
Publisher
Elsevier BV
Published
2012-12
Volume
225
Issue
2
Pages
370-375
ISSN
0021-9150
Cited by
20
References
5
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review